These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30677023)

  • 1. Kinetic and thermodynamic insights into sodium ion translocation through the μ-opioid receptor from molecular dynamics and machine learning analysis.
    Hu X; Wang Y; Hunkele A; Provasi D; Pasternak GW; Filizola M
    PLoS Comput Biol; 2019 Jan; 15(1):e1006689. PubMed ID: 30677023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atomic-Level Characterization of the Methadone-Stabilized Active Conformation of
    Kapoor A; Provasi D; Filizola M
    Mol Pharmacol; 2020 Oct; 98(4):475-486. PubMed ID: 32680919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular details of dimerization kinetics reveal negligible populations of transient µ-opioid receptor homodimers at physiological concentrations.
    Meral D; Provasi D; Prada-Gracia D; Möller J; Marino K; Lohse MJ; Filizola M
    Sci Rep; 2018 May; 8(1):7705. PubMed ID: 29769636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the molecular basis of agonist/antagonist mechanism of human mu opioid receptor through gaussian accelerated molecular dynamics method.
    Wang YT; Chan YH
    Sci Rep; 2017 Aug; 7(1):7828. PubMed ID: 28798303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An efficient strategy to estimate thermodynamics and kinetics of G protein-coupled receptor activation using metadynamics and maximum caliber.
    Meral D; Provasi D; Filizola M
    J Chem Phys; 2018 Dec; 149(22):224101. PubMed ID: 30553249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic and Kinetic Elements of µ-Opioid Receptor Functional Selectivity.
    Kapoor A; Martinez-Rosell G; Provasi D; de Fabritiis G; Filizola M
    Sci Rep; 2017 Sep; 7(1):11255. PubMed ID: 28900175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How Oliceridine (TRV-130) Binds and Stabilizes a μ-Opioid Receptor Conformational State That Selectively Triggers G Protein Signaling Pathways.
    Schneider S; Provasi D; Filizola M
    Biochemistry; 2016 Nov; 55(46):6456-6466. PubMed ID: 27778501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of μ-Opioid Receptor-Magnesium Interaction and Positive Allosteric Modulation.
    Hu X; Provasi D; Ramsey S; Filizola M
    Biophys J; 2020 Feb; 118(4):909-921. PubMed ID: 31676132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular dynamics of fentanyl bound to μ-opioid receptor.
    Lipiński PFJ; Jarończyk M; Dobrowolski JC; Sadlej J
    J Mol Model; 2019 May; 25(5):144. PubMed ID: 31053968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allosteric modulation model of the mu opioid receptor by herkinorin, a potent not alkaloidal agonist.
    Marmolejo-Valencia AF; Martínez-Mayorga K
    J Comput Aided Mol Des; 2017 May; 31(5):467-482. PubMed ID: 28364251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico studies of conformational dynamics of Mu opioid receptor performed using gaussian accelerated molecular dynamics.
    Liao JM; Wang YT
    J Biomol Struct Dyn; 2019 Jan; 37(1):166-177. PubMed ID: 29277141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Lipid Composition and Receptor Conformation on the Spatio-temporal Organization of μ-Opioid Receptors in a Multi-component Plasma Membrane Model.
    Marino KA; Prada-Gracia D; Provasi D; Filizola M
    PLoS Comput Biol; 2016 Dec; 12(12):e1005240. PubMed ID: 27959924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. To probe interaction of morphine and IBNtxA with 7TM and 6TM variants of the human μ-opioid receptor using all-atom molecular dynamics simulations with an explicit membrane.
    Sader S; Anant K; Wu C
    Phys Chem Chem Phys; 2018 Jan; 20(3):1724-1741. PubMed ID: 29265141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium-induced population shift drives activation of thrombin.
    Kahler U; Kamenik AS; Kraml J; Liedl KR
    Sci Rep; 2020 Jan; 10(1):1086. PubMed ID: 31974511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Na
    Xiao J; Salsbury FR
    Phys Chem Chem Phys; 2019 Feb; 21(8):4320-4330. PubMed ID: 30724273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Determinants for the Binding of Morphinan Agonists to the μ-Opioid Receptor.
    Cong X; Campomanes P; Kless A; Schapitz I; Wagener M; Koch T; Carloni P
    PLoS One; 2015; 10(8):e0135998. PubMed ID: 26280453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential Desensitization Observed at Multiple Effectors of Somatic μ-Opioid Receptors Underlies Sustained Agonist-Mediated Inhibition of Proopiomelanocortin Neuron Activity.
    Fox PD; Hentges ST
    J Neurosci; 2017 Sep; 37(36):8667-8677. PubMed ID: 28821664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of forebrain μ-opioid receptor signaling by low concentrations of rimonabant does not require cannabinoid receptors and directly involves μ-opioid receptors.
    Zádor F; Otvös F; Benyhe S; Zimmer A; Páldy E
    Neurochem Int; 2012 Aug; 61(3):378-88. PubMed ID: 22613132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noladin ether, a putative endocannabinoid, inhibits mu-opioid receptor activation via CB2 cannabinoid receptors.
    Páldyová E; Bereczki E; Sántha M; Wenger T; Borsodi A; Benyhe S
    Neurochem Int; 2008 Jan; 52(1-2):321-8. PubMed ID: 17698254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biosensor-based kinetic and thermodynamic characterization of opioids interaction with human μ-opioid receptor.
    Babazada H; Alekberli T; Hajieva P; Farajov E
    Eur J Pharm Sci; 2019 Oct; 138():105017. PubMed ID: 31356868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.